KAPA
Kairos Pharma (KAPA)
$74
About Kairos Pharma (KAPA)
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Details
Daily high
$0.75
Daily low
$0.71
Price at open
$0.75
52 Week High
$3.25
52 Week Low
$0.40
Market cap
15.4M
Dividend yield
0.00%
Volume
126,072
Avg. volume
136,021
P/E ratio
-2.44
Kairos Pharma News
Details
Daily high
$0.75
Daily low
$0.71
Price at open
$0.75
52 Week High
$3.25
52 Week Low
$0.40
Market cap
15.4M
Dividend yield
0.00%
Volume
126,072
Avg. volume
136,021
P/E ratio
-2.44